206 related articles for article (PubMed ID: 27191655)
1. rs965513 polymorphism as a common risk marker is associated with papillary thyroid cancer.
Wang F; Yan D; Ji X; Han J; Chen M; Qiao H; Zhang S
Oncotarget; 2016 Jul; 7(27):41336-41345. PubMed ID: 27191655
[TBL] [Abstract][Full Text] [Related]
2. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
[TBL] [Abstract][Full Text] [Related]
3. Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2.
He H; Li W; Liyanarachchi S; Jendrzejewski J; Srinivas M; Davuluri RV; Nagy R; de la Chapelle A
J Clin Endocrinol Metab; 2015 Jan; 100(1):E164-72. PubMed ID: 25303483
[TBL] [Abstract][Full Text] [Related]
4. Genotype Analyses in the Japanese and Belarusian Populations Reveal Independent Effects of rs965513 and rs1867277 but Do Not Support the Role of FOXE1 Polyalanine Tract Length in Conferring Risk for Papillary Thyroid Carcinoma.
Nikitski AV; Rogounovitch TI; Bychkov A; Takahashi M; Yoshiura KI; Mitsutake N; Kawaguchi T; Matsuse M; Drozd VM; Demidchik Y; Nishihara E; Hirokawa M; Miyauchi A; Rubanovich AV; Matsuda F; Yamashita S; Saenko VA
Thyroid; 2017 Feb; 27(2):224-235. PubMed ID: 27824288
[TBL] [Abstract][Full Text] [Related]
5. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
[TBL] [Abstract][Full Text] [Related]
6. Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian population.
Maillard S; Damiola F; Clero E; Pertesi M; Robinot N; Rachédi F; Boissin JL; Sebbag J; Shan L; Bost-Bezeaud F; Petitdidier P; Doyon F; Xhaard C; Rubino C; Blanché H; Drozdovitch V; Lesueur F; de Vathaire F
PLoS One; 2015; 10(4):e0123700. PubMed ID: 25849217
[TBL] [Abstract][Full Text] [Related]
7. Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.
Kula D; Kalemba M; Puch Z; Polańska J; Świerniak M; Rusinek D; Żebracka-Gala J; Kowalska M; Handkiewicz-Junak D; Kowal M; Tyszkiewicz T; Piasna E; Czarniecka A; Pawlaczek A; Krajewska J; Szpak-Ulczok S; Jarząb B
Endokrynol Pol; 2017; 68(3):283-289. PubMed ID: 28660995
[TBL] [Abstract][Full Text] [Related]
8. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
[TBL] [Abstract][Full Text] [Related]
9. MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus.
Wang Y; He H; Li W; Phay J; Shen R; Yu L; Hancioglu B; de la Chapelle A
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):474-479. PubMed ID: 28049826
[TBL] [Abstract][Full Text] [Related]
10. The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl.
Takahashi M; Saenko VA; Rogounovitch TI; Kawaguchi T; Drozd VM; Takigawa-Imamura H; Akulevich NM; Ratanajaraya C; Mitsutake N; Takamura N; Danilova LI; Lushchik ML; Demidchik YE; Heath S; Yamada R; Lathrop M; Matsuda F; Yamashita S
Hum Mol Genet; 2010 Jun; 19(12):2516-23. PubMed ID: 20350937
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
[TBL] [Abstract][Full Text] [Related]
12. FOXE1 association with differentiated thyroid cancer and its progression.
Penna-Martinez M; Epp F; Kahles H; Ramos-Lopez E; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Holzer K; Bechstein WO; Zeuzem S; Vorländer C; Badenhoop K
Thyroid; 2014 May; 24(5):845-51. PubMed ID: 24325646
[TBL] [Abstract][Full Text] [Related]
13. Associations between rs965513/rs944289 and papillary thyroid carcinoma risk: a meta-analysis.
Ai L; Liu X; Yao Y; Yu Y; Sun H; Yu Q
Endocrine; 2014 Nov; 47(2):428-34. PubMed ID: 24723258
[TBL] [Abstract][Full Text] [Related]
14. Relationships of FOXE1 and ATM genetic polymorphisms with papillary thyroid carcinoma risk: a meta-analysis.
Kang J; Deng XZ; Fan YB; Wu B
Tumour Biol; 2014 Jul; 35(7):7085-96. PubMed ID: 24756757
[TBL] [Abstract][Full Text] [Related]
15. Risk genetic polymorphism and haplotype associated with papillary thyroid cancer and their relation to associated diseases in Slovak population.
Duffek M; Skerenova M; Halasova E; Sarlinova M; Dzian A; Repiska V; Dobrovodsky A; Mistuna D; Bernadic M; Matakova T
Bratisl Lek Listy; 2022; 123(7):475-48. PubMed ID: 35907052
[TBL] [Abstract][Full Text] [Related]
16. Association of FOXE1 polyalanine repeat region with papillary thyroid cancer.
Bullock M; Duncan EL; O'Neill C; Tacon L; Sywak M; Sidhu S; Delbridge L; Learoyd D; Robinson BG; Ludgate M; Clifton-Bligh RJ
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1814-9. PubMed ID: 22736773
[TBL] [Abstract][Full Text] [Related]
17. Common genetic variants on FOXE1 contributes to thyroid cancer susceptibility: evidence based on 16 studies.
Zhuang Y; Wu W; Liu H; Shen W
Tumour Biol; 2014 Jun; 35(6):6159-66. PubMed ID: 24744143
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of common genetic variants on FOXE1 and differentiated thyroid cancer risk.
Zhu H; Xi Q; Liu L; Wang J; Gu M
PLoS One; 2014; 9(1):e87332. PubMed ID: 24489898
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide association study identifies a novel susceptibility gene for serum TSH levels in Chinese populations.
Zhan M; Chen G; Pan CM; Gu ZH; Zhao SX; Liu W; Wang HN; Ye XP; Xie HJ; Yu SS; Liang J; Gao GQ; Yuan GY; Zhang XM; Zuo CL; Su B; Huang W; Ning G; Chen SJ; Chen JL; Song HD;
Hum Mol Genet; 2014 Oct; 23(20):5505-17. PubMed ID: 24852370
[TBL] [Abstract][Full Text] [Related]
20. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.
Gudmundsson J; Sulem P; Gudbjartsson DF; Jonasson JG; Sigurdsson A; Bergthorsson JT; He H; Blondal T; Geller F; Jakobsdottir M; Magnusdottir DN; Matthiasdottir S; Stacey SN; Skarphedinsson OB; Helgadottir H; Li W; Nagy R; Aguillo E; Faure E; Prats E; Saez B; Martinez M; Eyjolfsson GI; Bjornsdottir US; Holm H; Kristjansson K; Frigge ML; Kristvinsson H; Gulcher JR; Jonsson T; Rafnar T; Hjartarsson H; Mayordomo JI; de la Chapelle A; Hrafnkelsson J; Thorsteinsdottir U; Kong A; Stefansson K
Nat Genet; 2009 Apr; 41(4):460-4. PubMed ID: 19198613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
